Drug companies spend millions to keep charging high prices
Pharmaceutical heavyweight Mylan, the latest poster child for drug-industry greed, finally stuck up for itself Thursday. It argued that the system, not avarice, was to blame for the company jacking up the price of EpiPens, a common (and life-saving) allergy remedy, by over 400%.
<snip>
Despite Mylans offer Thursday of discount coupons for some EpiPen users, the only system at work here is a cash-fat industry routinely preying on sick people. Its a system that the drug industry will do whatevers necessary to protect.
Of roughly $250 million raised for and against 17 ballot measures coming before California voters in November, more than a quarter of that amount about $70 million has been contributed by deep-pocketed drug companies to defeat the states Drug Price Relief Act.
Contributions aimed at killing the initiative are on track to be the most raised involving a single ballot measure since 2001, the earliest year for which online data are available, according to MapLight, a nonpartisan organization that tracks money in politics.
The Drug Price Relief Act would make prescription drugs more affordable for people in Medi-Cal and other state programs by requiring that California pay no more than whats paid for the same drugs by the U.S. Department of Veterans Affairs. It would, in other words, protect state taxpayers from being ripped off.
Industry donations to crush the Drug Price Relief Act will top $100 million by the election, Im quite certain of it,...
http://www.latimes.com/business/lazarus/la-fi-lazarus-drug-prices-20160826-snap-story.html